01Mar 2022
Therapeutic strategy analysis of patients with advanced stage high‐grade neuroendocrine cervical cancer: A real‐world multicenter study

Therapeutic strategy analysis of patients with advanced stage high‐grade neuroendocrine cervical cancer: A real‐world multicenter study

The objective was to explore the management of high‐grade neuroendocrine cervical cancer (HGNECC) since there has been no standard treatment for it. A total of 43 patients were included in the study. Paclitaxel plus cisplatin or paclitaxel plus carboplatin may be more effective than etoposide plus cisplatin. Radical surgery followed by chemotherapy may be a favorable alternative intervention for selected patients with advanced-stage cancer.

  • #gynaecology - ivf

Like

Save

Share